TCT-1 Anti-CEACAM6 monoclonal antibody

Product Design:
- Hu ScFv: fraction of mAb humanized (specific binding with low tox and immunogenicity profile)
- ScFv: small protein (100 fold higher penetration than mAb)
- Triggers ADCC and CDD: induces specific apoptosis without damaging surrounding tissues
- PEGylated:long ½ life allowing lower dose, tox, and cost

TCT-2 NPM1 Small Molecule

Product Design:
- Induces targeted apoptosis
- Inhibits cell proliferation